Clinical trials for Cancer in United States

GammaPod Registry and Quality of Life Nomogram

Study ID: NCT03562273

Sponsor

University of Maryland, Baltimore

Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial

Study ID: NCT06593431

Sponsor

M.D. Anderson Cancer Center

Seleno-Lionin (SLM)-Axitinib-Pemmbrolizumabababababol.

Study ID: NCT05363631

Sponsor

Mohammed Milhem

Study With Various Immunotherapy Treatments in Participants With Lung Cancer

Study ID: NCT05676931

Sponsor

Gilead Sciences

Study of Personalized Cancer Therapy to Determine Response and Toxicity

Study ID: NCT02478931

Sponsor

Species name

Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence

Study ID: NCT02446431

Sponsor

Miller Children's & Women's Hospital Long Beach

Assessment of Patient Experience and Needs for Patients Undergoing Invasive Inguinal Lymph Node Procedures for Penile Cancer

Study ID: NCT05842031

Sponsor

M.D. Anderson Cancer Center

Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma

Study ID: NCT05960773

Sponsor

National Cancer Institute (NCI)

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

Study ID: NCT05803382

Sponsor

National Cancer Institute (NCI)

myCare-102: Clinical Utility and Usability of Cellworks Singula™ and Cellworks Ventura™ Reports

Study ID: NCT05693831

Sponsor

Cellworks Group Inc.